INTRODUCTION
Osteomyelitis of the spine accounts for 2%-7% of all bony infections. Only 10% of spondylodiscitis cases involve the cervical spine. [2, 8] Cervical spine Candida infections are extremely rare and typically occur in only immunocompromised patients, [7, 8] or those on prolonged antibiotics, or with central venous catheters. [2, 3] Here, we present a case of cervical Candida spondylodiscitis in a non-immunocompromised male at the C6-C7 level, along literature review.
CASE DESCRIPTION History and physical examination
A 32-year-old male with a history of intravenous drug use and hepatitis B and C presented with a 2-month history of progressive limited cervical range of motion, neck pain, bilateral upper extremity weakness, and paresthesias. His examination revealed mild 4/5 bilateral upper extremity weakness, right greater than left, with mild bilateral hyperreflexia, and significant kyphosis. 
Diagnostic workup

Laboratory studies
Laboratory studies demonstrated nonspecific markers of inflammation (e.g., erythrocyte sedimentation rate [ESR] of 24 mm/h, and C-reactive protein [CRP] of 23.1 mg/L). Blood cultures before antibiotic or antifungal therapy were negative. e patient tested negative for human immunodeficiency virus and tuberculosis.
Hospital course
e patient underwent a C6 and C7 anterior corpectomy with instrumented fusion (e.g., placement of an expandable cervical cage and C5 to thoracic [T] 1 anteriorly). Intraoperatively, frank pus was noted within the C6-C7 disc space and was accompanied by thick prevertebral and epidural phlegmon extending from C5 to T1. ree days later, a C6-C7 laminectomy with C4-T2 posterior instrumented fusion was performed [ Figure 2 ]. Intraoperative cultures again grew only Candida albicans. He was treated with intravenous micafungin followed by 6-12 months of 400 mg fluconazole. ree months postoperatively, the patient is doing well without complication but is continuing his oral antifungal therapy along with physical therapy.
DISCUSSION
e most common pathogen involved in spondylodiscitis is Staphylococcus aureus. With the current increase of broad-spectrum antibiotics and central venous catheter use, the incidence of fungal spondylodiscitis is on the rise. e involvement of Candida species is rare and only occurs in 0.3%-2% cases of spondylodiscitis. [1, 3, 7] e most prevalent species in Candida spondylodiscitis is C. albicans followed by Candida glabrata and Candida tropicalis.
Risk factors
Risk factors for C. albicans spondylodiscitis include long courses of broad-spectrum antibiotics, central venous catheter use, intravenous drug use, poorly controlled diabetes, immunosuppressive therapies, and spinal surgeries. [1] [2] [3] Here, the patient presented with a history of intravenous drug use, but no immunosuppression.
Laboratory studies for Candida spondylodiscitis
Candida spondylodiscitis can occur either as a result of a contiguous infection, direct inoculation (through lumbar puncture, spinal anesthesia, or spinal surgery), or hematogenous spread after prolonged candidemia. e classical time interval between the initial candidemia and onset of spondylodiscitis is several months. [3, 4, 6] e laboratory markers for inflammation such as white blood cell count, ESR, and CRP are often equivocal.
XR, magnetic resonance, and computed tomography of Candida spondylodiscitis
MRI is the best imaging modality for spondylodiscitis; it delineates early erosive bony changes consisting of hypointensities in the vertebral bodies on T1-weighted images, the absence of disc hyperintensity, and preservation of the intranuclear cleft in the disc on T2-weighted images. [3, 5, 6] Plain radiographs and CT spinal images may later detect vertebral abnormalities in conjunction with Candida spondylodiscitis. e definitive diagnosis typically requires image-guided biopsy, surgery, and/or direct documentation with fungal studies. [4, 5] 
Treatment of Candida spondylodiscitis
Candida osteomyelitis can be treated nonoperatively with a prolonged course of fluconazole or a lipid formulation of amphotericin B. Where applicable, optimizing risk factors such as tight glycemic control (e.g., in diabetics) or prompt removal of central venous catheters are often advocated. Surgical intervention may be necessary, particularly where nonsurgical measures fail. Critically, any evidence of new/progressive neurological deficits or radiological findings of significant spinal cord compression/instability may warrant surgical decompression with/without fusion. [1, 4] 
CONCLUSION
Cervical spondylodiscitis caused by C. albicans is rare, especially in non-immunocompromised patients. For those who present with progressive neurological deterioration, MR followed by CT findings of compressive/erosive/ osteomyelitis pathology warrants surgical intervention to avoid long-term sequelae.
